STOCKSCREENR

HKPD

NASDAQ

Cellyan Biotechnology Co., Ltd

$0.63-0.04(-6.72%)Mkt Cap: $6.86M

Key Stats

Market Cap

$6.86M

P/E Ratio

-10.42

EPS

$-0.06

Dividend Yield

0.00%

52-Week Range

$0.37 — $2.76

Volume

4.71K

Avg Volume

38.09K

Beta

3.19

Price Alerts for HKPD

Get alerted when HKPD hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-10.42

Forward P/E

—

PEG Ratio

2.44

P/S (TTM)

0.39

P/B (TTM)

1.32

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.01%

ROA (TTM)

-0.00%

ROIC

—

Gross Margin

0.12%

Operating Margin

0.01%

Net Margin

—

Debt/Equity

0.48

Current Ratio

2.99

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.01%

EPS Growth (5Y)

-0.01%

Sales Growth (3Y)

+0.18%

Sales Growth (5Y)

+0.18%

EPS Est (This Year)

—

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.33

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

11.00M

Float

3.21M

Free Float %

29.21%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

HK

Exchange

NASDAQ

IPO Date

2025-01-15

Employees

27

CEO

Chenyu Liang

Index Membership

—

Website

http://www.9zt.hk

Cellyan Biotechnology Co., Ltd (HKPD) is a healthcare company in the medical - pharmaceuticals industry listed on the NASDAQ. With a market capitalization of $6.86M, a P/E ratio of -10.42, HKPD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HKPD against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

MSLE

Satellos Bioscience Inc. Common Stock

$7.95

+9.35%

$10.24M

KYNB

Kyntra Bio, Inc.

$7.27

+3.12%

$29.42M

0QFK.L

Celyad Oncology S.A.

$0.17

+2.94%

$4.83M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

NEUP

Neuphoria Therapeutics Inc.

$5.27

+1.54%

$28.41M

Frequently Asked Questions

What is Cellyan Biotechnology Co., Ltd's P/E ratio?

Cellyan Biotechnology Co., Ltd (HKPD) has a trailing twelve-month (TTM) P/E ratio of -10.42. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Cellyan Biotechnology Co., Ltd pay a dividend?

No, Cellyan Biotechnology Co., Ltd (HKPD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Cellyan Biotechnology Co., Ltd's market cap?

Cellyan Biotechnology Co., Ltd (HKPD) has a market capitalization of $6.86 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.